Biogen Long Term Debt 2006-2019 | BIIB

Biogen long term debt from 2006 to 2019. Long term debt can be defined as the sum of all long term debt fields.
  • Biogen long term debt for the quarter ending March 31, 2019 was $5.943B, a 0.23% increase year-over-year.
  • Biogen long term debt for 2018 was $5.937B, a 0.03% increase from 2017.
  • Biogen long term debt for 2017 was $5.935B, a 8.87% decline from 2016.
  • Biogen long term debt for 2016 was $6.513B, a 0.13% decline from 2015.
Biogen Annual Long Term Debt
(Millions of US $)
2018 $5,937
2017 $5,935
2016 $6,513
2015 $6,522
2014 $580
2013 $592
2012 $687
2011 $1,061
2010 $1,066
2009 $1,080
2008 $1,085
2007 $52
2006 $97
2005 $43
Biogen Quarterly Long Term Debt
(Millions of US $)
Q1 2019 $5,943
Q4 2018 $5,937
Q3 2018 $5,931
Q2 2018 $5,928
Q1 2018 $5,929
Q4 2017 $5,935
Q3 2017 $5,938
Q2 2017 $5,954
Q1 2017 $5,953
Q4 2016 $6,513
Q3 2016 $6,530
Q2 2016 $6,538
Q1 2016 $6,536
Q4 2015 $6,522
Q3 2015 $6,529
Q2 2015 $576
Q1 2015 $581
Q4 2014 $580
Q3 2014 $584
Q2 2014 $586
Q1 2014 $591
Q4 2013 $592
Q3 2013 $695
Q2 2013 $726
Q1 2013 $712
Q4 2012 $687
Q3 2012 $658
Q2 2012 $642
Q1 2012 $626
Q4 2011 $1,061
Q3 2011 $1,061
Q2 2011 $1,063
Q1 2011 $1,066
Q4 2010 $1,066
Q3 2010 $1,069
Q2 2010 $1,070
Q1 2010 $1,076
Q4 2009 $1,080
Q3 2009 $1,086
Q2 2009 $1,086
Q1 2009 $1,083
Q4 2008 $1,085
Q3 2008 $1,042
Q2 2008 $1,038
Q1 2008 $1,060
Q4 2007 $52
Q3 2007 $50
Q2 2007 $51
Q1 2007 $52
Q4 2006 $97
Q3 2006 $45
Q2 2006 $45
Q1 2006 $44
Q4 2005 $43
Q3 2005 $43
Q2 2005 $42
Q1 2005 $95
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $44.456B $13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $103.634B 11.72
Gilead Sciences (GILD) United States $84.602B 10.27
Celgene (CELG) United States $67.296B 11.40
Illumina (ILMN) United States $45.222B 52.41
Vertex Pharmaceuticals (VRTX) United States $43.215B 52.24
Regeneron Pharmaceuticals (REGN) United States $33.323B 15.66
Alexion Pharmaceuticals (ALXN) United States $29.353B 16.61
Incyte (INCY) United States $16.555B 67.13
BioMarin Pharmaceutical (BMRN) United States $15.885B 0.00
Exact Sciences (EXAS) United States $12.422B 0.00
Seattle Genetics (SGEN) United States $10.715B 0.00
Sarepta Therapeutics (SRPT) United States $9.022B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.999B 47.71
QIAGEN (QGEN) Netherlands $8.360B 27.46
BeiGene (BGNE) Cayman Islands $7.863B 0.00
Moderna (MRNA) United States $7.594B 0.00
Bio-Techne Corp (TECH) United States $7.478B 51.02
Alnylam Pharmaceuticals (ALNY) United States $7.196B 0.00
Bluebird Bio (BLUE) United States $7.074B 0.00
Guardant Health (GH) United States $6.636B 0.00
Exelixis (EXEL) United States $5.833B 14.87
Galapagos (GLPG) Belgium $5.782B 0.00
Amarin (AMRN) Ireland $5.745B 0.00
Ascendis Pharma (ASND) Denmark $5.156B 0.00
Array BioPharma (ARRY) United States $4.847B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.138B 0.00
Spark Therapeutics (ONCE) United States $4.135B 0.00
Blueprint Medicines (BPMC) United States $3.972B 0.00
Alkermes (ALKS) Ireland $3.899B 0.00
China Biologic Products (CBPO) China $3.665B 23.27
ACADIA Pharmaceuticals (ACAD) United States $3.608B 0.00
Allogene Therapeutics (ALLO) United States $3.548B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.531B 0.00
Global Blood Therapeutics (GBT) United States $3.304B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.275B 0.00
Repligen (RGEN) United States $3.176B 79.12
Immunomedics (IMMU) United States $2.990B 0.00
Amicus Therapeutics (FOLD) United States $2.823B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.744B 0.00
Reata Pharmaceuticals (RETA) United States $2.728B 0.00
Arena Pharmaceuticals (ARNA) United States $2.677B 5.44
Mirati Therapeutics (MRTX) United States $2.664B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.574B 0.00
Medicines (MDCO) United States $2.438B 0.00
MyoKardia (MYOK) United States $2.287B 0.00
Emergent Biosolutions (EBS) United States $2.274B 19.75
Halozyme Therapeutics (HALO) United States $2.271B 0.00
Insmed (INSM) United States $2.263B 0.00
UniQure (QURE) Netherlands $2.258B 0.00
Ligand Pharmaceuticals (LGND) United States $2.255B 18.68
Acceleron Pharma (XLRN) United States $2.200B 0.00
NeoGenomics (NEO) United States $2.192B 143.69
CRISPR Therapeutics AG (CRSP) Switzerland $2.055B 0.00
Genomic Health (GHDX) United States $2.009B 42.66
Denali Therapeutics (DNLI) United States $1.978B 0.00
Akcea Therapeutics (AKCA) United States $1.918B 0.00
AnaptysBio (ANAB) United States $1.917B 0.00
Myriad Genetics (MYGN) United States $1.908B 18.98
Allakos (ALLK) United States $1.864B 0.00
Lion Biotechnologies (IOVA) United States $1.856B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.798B 0.00
Audentes Therapeutics (BOLD) United States $1.743B 0.00
REGENXBIO (RGNX) United States $1.638B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.611B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.580B 0.00
Innoviva (INVA) United States $1.478B 4.09
Cambrex (CBM) United States $1.444B 18.25
Alector (ALEC) United States $1.399B 0.00
Gossamer Bio (GOSS) United States $1.382B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.303B 0.00
Coherus BioSciences (CHRS) United States $1.286B 0.00
Aimmune Therapeutics (AIMT) United States $1.257B 0.00
Rubius Therapeutics (RUBY) United States $1.253B 0.00
Fate Therapeutics (FATE) United States $1.222B 0.00
Sangamo Therapeutics (SGMO) United States $1.176B 0.00
Apellis Pharmaceuticals (APLS) United States $1.138B 0.00
Atara Biotherapeutics (ATRA) United States $1.111B 0.00
Editas Medicine (EDIT) United States $1.108B 0.00
Epizyme (EPZM) United States $1.101B 0.00
RA PHARMCTL INC (RARX) United States $1.036B 0.00
Codexis (CDXS) United States $1.036B 0.00
InflaRx (IFRX) Germany $1.035B 0.00
Eidos Therapeutics (EIDX) United States $0.983B 0.00
Athenex (ATNX) United States $0.934B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.925B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.912B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.907B 0.00
Clovis Oncology (CLVS) United States $0.905B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.904B 0.00
WAVE Life Sciences (WVE) Singapore $0.898B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.891B 0.00
Myovant Sciences (MYOV) United Kingdom $0.884B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.879B 0.00
NGM Biopharmaceuticals (NGM) United States $0.864B 0.00
G1 THERAPEUTICS (GTHX) United States $0.847B 0.00
ANI Pharmaceuticals (ANIP) United States $0.842B 14.94
Dicerna Pharmaceuticals (DRNA) United States $0.827B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.821B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.810B 38.22
Retrophin (RTRX) United States $0.788B 0.00
MeiraGTx Holdings (MGTX) United States $0.783B 0.00
Cellectis (CLLS) France $0.777B 0.00
Axsome Therapeutics (AXSM) United States $0.769B 0.00
Principia Biopharma (PRNB) United States $0.762B 0.00
Cara Therapeutics (CARA) United States $0.756B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.729B 0.00
Arvinas (ARVN) United States $0.719B 0.00
Vericel (VCEL) United States $0.718B 0.00
Twist Bioscience (TWST) United States $0.718B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.716B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.712B 0.00
Intellia Therapeutics (NTLA) United States $0.711B 0.00
Intra-Cellular Therapies (ITCI) United States $0.690B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.659B 0.00
Puma Biotechnology (PBYI) United States $0.641B 0.00
Stemline Therapeutics (STML) United States $0.636B 0.00
Precision BioSciences (DTIL) United States $0.628B 0.00
Kura Oncology (KURA) United States $0.614B 0.00
Zealand Pharma (ZEAL) Denmark $0.611B 7.14
Heska (HSKA) United States $0.606B 62.01
Viking Therapeutics (VKTX) United States $0.604B 0.00
Cytokineticsorporated (CYTK) United States $0.601B 0.00
ObsEva SA (OBSV) Switzerland $0.593B 0.00
Zymeworks (ZYME) Canada $0.578B 0.00
Adverum Biotechnologies (ADVM) United States $0.574B 0.00
Scholar Rock Holding (SRRK) United States $0.561B 0.00
Magenta Therapeutics (MGTA) United States $0.557B 0.00
MediciNova (MNOV) United States $0.546B 0.00
DBV Technologies (DBVT) France $0.546B 0.00
Acorda Therapeutics (ACOR) United States $0.530B 9.34
UROGEN PHARMA (URGN) United States $0.526B 0.00
Anika Therapeutics (ANIK) United States $0.525B 17.93
Revance Therapeutics (RVNC) United States $0.524B 0.00
Synthorx (THOR) United States $0.515B 0.00
Mesoblast (MESO) Australia $0.487B 0.00
CytomX Therapeutics (CTMX) United States $0.485B 0.00
Krystal Biotech (KRYS) United States $0.482B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.470B 0.00
Replimune (REPL) United States $0.467B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.447B 0.00
Sorrento Therapeutics (SRNE) United States $0.446B 0.00
Kaleido Biosciences (KLDO) $0.442B 0.00
Albireo Pharma (ALBO) United States $0.433B 0.00
AVROBIO (AVRO) United States $0.432B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.425B 0.00
Arcus Biosciences (RCUS) United States $0.421B 0.00
Dynavax Technologies (DVAX) United States $0.410B 0.00
Cyclerion Therapeutics (CYCN) United States $0.400B 0.00
BioDelivery Sciences (BDSI) United States $0.400B 0.00
Gritstone Oncology (GRTS) United States $0.399B 0.00
Agenus (AGEN) United States $0.396B 0.00
Kezar Life Sciences (KZR) United States $0.390B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.384B 0.00
Senesco Technologies (ELOX) United States $0.384B 0.00
UNITY Biotechnology (UBX) $0.383B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.383B 0.00
Prothena (PRTA) Ireland $0.380B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Abeona Therapeutics (ABEO) United States $0.366B 0.00
PDL BioPharma (PDLI) United States $0.363B 8.60
AMAG Pharmaceuticals (AMAG) United States $0.349B 0.00
AC Immune SA (ACIU) Switzerland $0.344B 22.13
BeyondSpring (BYSI) United States $0.342B 0.00
Kodiak Sciences (KOD) United States $0.333B 0.00
Five Prime Therapeutics (FPRX) United States $0.332B 0.00
LogicBio Therapeutics (LOGC) United States $0.332B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.328B 0.00
XBiotech (XBIT) United States $0.328B 0.00
Merus (MRUS) Netherlands $0.328B 0.00
Kindred Biosciences (KIN) United States $0.328B 0.00
Inovio Pharmaceuticals (INO) United States $0.327B 0.00
Cellular Biomedicine (CBMG) United States $0.305B 0.00
HOOKIPA PHARMA (HOOK) United States $0.304B 0.00
Kadmon Holdings (KDMN) United States $0.297B 0.00
Athersys (ATHX) United States $0.295B 0.00
Palatin Technologies (PTN) United States $0.290B 0.00
Geron (GERN) United States $0.284B 0.00
ResTORbio (TORC) United States $0.282B 0.00
Constellation Pharmaceuticals (CNST) United States $0.274B 0.00
PHASEBIO PHARMA (PHAS) United States $0.263B 0.00
ChromaDex (CDXC) United States $0.253B 0.00
Protagonist Therapeutics (PTGX) United States $0.253B 0.00
Aduro Biotech (ADRO) United States $0.251B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.246B 0.00
Evelo Biosciences (EVLO) United States $0.240B 0.00
MannKind (MNKD) United States $0.238B 0.00
Arsanis (XFOR) United States $0.232B 0.00
Celcuity (CELC) United States $0.231B 0.00
Kamada (KMDA) Israel $0.231B 8.95
Cerecor (CERC) United States $0.230B 0.00
Urovant Sciences (UROV) United States $0.224B 0.00
Sutro Biopharma (STRO) United States $0.224B 0.00
Mersana Therapeutics (MRSN) United States $0.223B 0.00
Enochian BioSciences (ENOB) United States $0.221B 0.00
Syros Pharmaceuticals (SYRS) United States $0.220B 0.00
OvaScience (MLND) United States $0.220B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.214B 0.00
Solid Biosciences (SLDB) United States $0.214B 0.00
Pfenex (PFNX) United States $0.213B 0.00
TOCAGEN INC (TOCA) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Synlogic (SYBX) United States $0.208B 0.00
Kala Pharmaceuticals (KALA) United States $0.202B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.199B 0.00
VBI Vaccines (VBIV) United States $0.198B 0.00
Neothetics (EVFM) United States $0.198B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.196B 0.00
Avid Bioservices (CDMO) United States $0.196B 0.00
Chiasma (CHMA) United States $0.190B 0.00
Celyad SA (CYAD) Belgium $0.189B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.187B 0.00
ADMA Biologics Inc (ADMA) United States $0.187B 0.00
Cel-Sci (CVM) United States $0.184B 0.00
Liquidia Technologies (LQDA) United States $0.183B 0.00
Gamida Cell (GMDA) Israel $0.181B 0.00
Compugen (CGEN) Israel $0.177B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.176B 0.00
Cue Biopharma (CUE) United States $0.175B 0.00
BioTime (BTX) United States $0.175B 11.70
CorMedix Inc (CRMD) United States $0.175B 0.00
Intec Pharma (NTEC) Israel $0.174B 0.00
Enzo Biochem (ENZ) United States $0.172B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
Anavex Life Sciences (AVXL) United States $0.170B 0.00
Seres Therapeutics (MCRB) United States $0.170B 0.00
Axovant Sciences (AXGT) United Kingdom $0.168B 0.00
Menlo Therapeutics (MNLO) United States $0.165B 0.00
Mustang Bio (MBIO) United States $0.164B 0.00
Strongbridge Biopharma (SBBP) United States $0.164B 9.47
Checkpoint Therapeutics (CKPT) United States $0.158B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.147B 0.00
Eton Pharmaceuticals (ETON) United States $0.146B 0.00
Provention Bio (PRVB) United States $0.146B 0.00
XOMA (XOMA) United States $0.141B 0.00
OSMOTICA PHARM (OSMT) United States $0.139B 0.00
Novavax (NVAX) United States $0.138B 0.00
Arbutus Biopharma (ABUS) Canada $0.136B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.129B 0.00
VolitionRX (VNRX) Singapore $0.128B 0.00
Trevena (TRVN) United States $0.125B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.120B 0.00
Organovo Holdings (ONVO) United States $0.118B 0.00
Aptinyx (APTX) United States $0.118B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.114B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.114B 0.00
Verastem (VSTM) United States $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.112B 0.00
INmune Bio (INMB) United States $0.111B 0.00
Dyadic (DYAI) United States $0.111B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.110B 0.00
Allena Pharmaceuticals (ALNA) United States $0.109B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.107B 0.00
Equillium (EQ) United States $0.107B 0.00
NantKwest (NK) United States $0.104B 0.00
Unum Therapeutics (UMRX) United States $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.101B 0.00
Selecta Biosciences (SELB) United States $0.100B 0.00
Pluristem Therapeutics (PSTI) Israel $0.093B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.092B 0.00
Cohbar (CWBR) United States $0.087B 0.00
Signal Genetics (MGEN) United States $0.087B 0.00
Aptose Biosciences (APTO) Canada $0.087B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.085B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.081B 85.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
VTv Therapeutics (VTVT) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.079B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.20
OVID THERAPEUTC (OVID) United States $0.068B 0.00
Alcobra (ARCT) United States $0.067B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
ScPharmaceuticals (SCPH) United States $0.065B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Eyenovia (EYEN) United States $0.062B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Ophthotech (ISEE) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
Apricus Biosciences (SEEL) United States $0.055B 0.00
Curis (CRIS) United States $0.054B 0.00
AZURRX BIOPHARM (AZRX) United States $0.054B 0.00
Cidara Therapeutics (CDTX) United States $0.054B 0.00
Zosano Pharma (ZSAN) United States $0.053B 0.00
Moleculin Biotech (MBRX) United States $0.052B 0.00
AEterna Zentaris (AEZS) United States $0.052B 0.00
Hoth Therapeutics (HOTH) United States $0.052B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Entera Bio (ENTX) Israel $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Celsion (CLSN) United States $0.044B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.043B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.041B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.041B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.039B 0.00
Aptevo Therapeutics (APVO) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Bionano Genomics (BNGO) United States $0.034B 0.00
Leap Therapeutics (LPTX) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
OncoSec Medical (ONCS) United States $0.029B 0.00
Motif Bio Plc (MTFB) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Vical (VICL) United States $0.026B 0.00
GTx (GTXI) United States $0.025B 0.00
Oncobiologics (OTLK) United States $0.025B 0.00
TRACON Pharmaceuticals (TCON) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Sophiris Bio (SPHS) United States $0.024B 0.00
Adial Pharmaceuticals (ADIL) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Oragenics (OGEN) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.020B 0.00
Galena Biopharma (SLS) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Aileron Therapeutics (ALRN) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
IMMURON LTD (IMRN) Australia $0.018B 0.00
Advaxis (ADXS) United States $0.017B 0.00
Histogenics (HSGX) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.82
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Edge Therapeutics (PDSB) United States $0.011B 0.00
Vital Therapies (IMUX) United States $0.011B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
BioPharmX (BPMX) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
AmpliPhi Biosciences (ARMP) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.007B 0.00
Alliqua BioMedical (ADYX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.002B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00